Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $258,255 - $297,303
-4,310 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $4,135 - $4,509
-69 Reduced 1.58%
4,310 $264,000
Q3 2017

Nov 09, 2017

BUY
$55.23 - $63.74 $30,210 - $34,865
547 Added 14.27%
4,379 $279,000
Q2 2017

Nov 03, 2017

BUY
N/A
3,832
3,832 $213,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Johnson Financial Group, LLC Portfolio

Follow Johnson Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, LLC with notifications on news.